trimethoprim has been researched along with Communicable Diseases, Emerging in 1 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Communicable Diseases, Emerging: Infectious diseases that are novel in their outbreak ranges (geographic and host) or transmission mode.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Actinomycosis is a chronic granulomatous condition that commonly manifests as cervicofacial, pulmonary, or abdominal disease, caused by slowly progressive infection with oral and gastrointestinal commensal Actinomyces species." | 1.35 | Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen. ( Beovic, B; Blanche, S; Brousse, N; Galmiche, L; Güngör, T; Holland, SM; Kayal, S; Lopatin, U; Mahlaoui, N; Reichenbach, J; Seger, RA; Siler, U; Zbinden, R, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reichenbach, J | 1 |
| Lopatin, U | 1 |
| Mahlaoui, N | 1 |
| Beovic, B | 1 |
| Siler, U | 1 |
| Zbinden, R | 1 |
| Seger, RA | 1 |
| Galmiche, L | 1 |
| Brousse, N | 1 |
| Kayal, S | 1 |
| Güngör, T | 1 |
| Blanche, S | 1 |
| Holland, SM | 1 |
1 other study available for trimethoprim and Communicable Diseases, Emerging
| Article | Year |
|---|---|
Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen.
Topics: Actinomyces; Actinomycosis; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Bon | 2009 |